Delta Crystallon is a privately owned biopharmaceutical company dedicated to the development of highly selective biotherapeutics for neurodegenerative disorders. The Company’s lead product is DC-TAB, a recombinant form of the human small heat shock protein alpha B-crystallin. Delta Crystallon is currently finalizing a randomized, double blind, placebo-controlled clinical Phase IIa study in relapsing-remitting multiple sclerosis patients. Strongly encouraged by the preliminary outcome of this study, preparations are underway for a next Phase IIb study. Recent developments have inspired Delta Crystallon to additionally target the orphan indications amyotrophic lateral sclerosis and progressive supranuclear palsy. Delta Crystallon was founded in 2008, and extends its cutting-edge internal R&D with a strong network of external expertise, both corporate and academic. Combining its own strengths with the complementary capabilities of partners that are the best in their field ensures the highest level of quality and expertise to support Delta Crystallon’s development program
View Top Employees from Delta CrystallonWebsite | http://www.deltacrystallon.com |
Revenue | $4.2 million |
Employees | 1 (0 on RocketReach) |
Founded | 2008 |
Address | Zernikedreef 9, Leiden, South Holland, NL |
Technologies |
JavaScript,
HTML,
Google Analytics
+7 more
(view full list)
|
Industry | Biotechnology Research, Drug Manufacturing & Research, Pharmaceuticals, Healthcare |
SIC | SIC Code 28 Companies, SIC Code 283 Companies, SIC Code 2834 Companies |
NAICS | NAICS Code 32 Companies, NAICS Code 3254 Companies, NAICS Code 32541 Companies, NAICS Code 325 Companies |
Looking for a particular Delta Crystallon employee's phone or email?
The Delta Crystallon annual revenue was $4.2 million in 2024.
Delta Crystallon is based in Leiden, South Holland.
The NAICS codes for Delta Crystallon are [32, 3254, 32541, 325].
The SIC codes for Delta Crystallon are [28, 283, 2834].